Home › Funds › Triata Capital Ltd › LEGN
Triata Capital Ltd position in LEGN
LEGEND BIOTECH CORP · Health Care
Triata Capital Ltd reported holding 989,014 shares of LEGN (LEGEND BIOTECH CORP) in its Q3 2026 13F filing — a position valued at US$19.7M, representing 3.70% of its reported portfolio and ranking #8 among its reported holdings. Triata Capital Ltd has disclosed LEGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Triata Capital Ltd's LEGN position evolved
Triata Capital Ltd first disclosed a stake in LEGN in Q2 2025 at 107,500 shares (US$3.8M). The position peaked in Q3 2026 at 989,014 shares, worth US$19.7M. Across 6 filings, Triata Capital Ltd increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 989,014 shares valued at US$19.7M — an increase of 359,100 shares quarter over quarter.. Notable position changes include a 56% increase in Q4 2025 (shares fell 17% over the following quarter), a 149% increase in Q1 2026 (shares rose 60% over the following quarter), a 57% increase in Q3 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 107.50K | $3.82M | New |
| Q3 2025 | 161.80K | $5.28M | Add |
| Q4 2025 | 252.60K | $5.49M | Add |
| Q1 2026 | 629.91K | $11.40M | Add |
| Q2 2026 | 629.91K | $18.19M | Hold |
| Q3 2026 | 989.01K | $19.67M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LEGN and 13F data
LEGN (LEGEND BIOTECH CORP) is a Health Care company. 15 other funds we track also report a position in LEGN — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$235.0M), MONTANOVA CAPITAL, LLC (US$204.2M), Hillhouse Capital (HHLR Advisors) (US$172.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LEGN
- DEERFIELD MANAGEMENT COMPANY, L.P. 8.14M sh · $235.01M · Q2 2026
- MONTANOVA CAPITAL, LLC 7.07M sh · $204.18M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 5.98M sh · $172.83M · Q2 2026
- Point72 Asset Management 3.08M sh · $88.84M · Q2 2026
- Kynam Capital Management, LP 3.00M sh · $86.67M · Q2 2026
- Soleus Capital Management, L.P. 1.21M sh · $34.80M · Q2 2026
- Ghisallo Capital Management LLC 1.00M sh · $28.88M · Q2 2026
More on Triata Capital Ltd
FAQ
How long has Triata Capital Ltd held LEGN?
Triata Capital Ltd has disclosed LEGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Triata Capital Ltd's current position in LEGN?
As of Q3 2026, Triata Capital Ltd holds 989.01K shares of LEGN (LEGEND BIOTECH CORP), valued at $19.67M, representing 3.70% of its reported portfolio and ranking #8.
Has Triata Capital Ltd been buying or selling LEGN?
In the latest 13F filing (Q3 2026), Triata Capital Ltd increased its position in LEGN. The position peaked in Q3 2026 at 989.01K shares.
Which other funds hold LEGN?
Other major institutional holders of LEGN include DEERFIELD MANAGEMENT COMPANY, L.P., MONTANOVA CAPITAL, LLC, Hillhouse Capital (HHLR Advisors), among 15 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.